Petros Grivas on Twitter
#GU23: very important data from KN057 trial presented by Dr. Necchi on pembro alone in pts with high-risk BCG-unresponsive Ta or T1 (no CIS): DFS rate, safety profile, qoL/PROs suggest that pembro can be an option in pts who decline or cannot undergo radical cystectomy